Cargando…

Long-Term Survivors with Metastatic Uveal Melanoma

BACKGROUND: To report the tumor, patient, and treatment characteristics of long-term metastatic uveal melanoma survivors. METHODS: A non-comparative, retrospective case series of patients from a single institution surviving >24 months with metastatic uveal melanoma (UM). RESULTS: Nine patients me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buzzacco, Dominic M, Abdel-Rahman, Mohamed H, Park, Stanley, Davidorf, Frederick, Olencki, Thomas, Cebulla, Colleen M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Open 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394198/ https://www.ncbi.nlm.nih.gov/pubmed/22798969 http://dx.doi.org/10.2174/1874364101206010049

Ejemplares similares

Heterogeneity in Mitogen-Activated Protein Kinase (MAPK) Pathway Activation in Uveal Melanoma With Somatic GNAQ and GNA11 Mutations
por: Boru, Getachew, et al.
Publicado: (2019)

Brachytherapy for patients with uveal melanoma: historical perspectives and future treatment directions
por: Brewington, Beatrice Y, et al.
Publicado: (2018)

Genetic markers of pigmentation are novel risk loci for uveal melanoma
por: Ferguson, Robert, et al.
Publicado: (2016)

BAP1 expression is prognostic in breast and uveal melanoma but not colon cancer and is highly positively correlated with RBM15B and USP19
por: Shahriyari, Leili, et al.
Publicado: (2019)

Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy
por: Khan, Shaheer, et al.
Publicado: (2022)

Clinical determinants of long-term survival in metastatic uveal melanoma
por: Koch, Elias A. T., et al.
Publicado: (2021)

Patterns of BAP1 protein expression provide insights into prognostic significance and the biology of uveal melanoma
por: Farquhar, Neil, et al.
Publicado: (2017)

Uveal melanoma: Long-term survival
por: Radivoyevitch, Tomas, et al.
Publicado: (2021)

Prognostic Factors and Decision Tree for Long-Term Survival in Metastatic Uveal Melanoma
por: Lorenzo, Daniel, et al.
Publicado: (2018)

Multimodal Imaging and Clinicopathologic Correlation in Primary Uveal Lymphoma
por: Erickson, Brandon, et al.
Publicado: (2016)

The genetic evolution of metastatic uveal melanoma
por: Shain, A. Hunter, et al.
Publicado: (2019)

Uveal melanoma-associated cancers revisited
por: Alfaar, Ahmad Samir, et al.
Publicado: (2020)

GNQ-209P Mutation in Metastatic Uveal Melanoma and Treatment Outcome
por: Abdel Karim, Nagla, et al.
Publicado: (2018)

Tissue-Based Microarray Expression of Genes Predictive of Metastasis in Uveal Melanoma and Differentially Expressed in Metastatic Uveal Melanoma
por: Demirci, Hakan, et al.
Publicado: (2013)

Treatment of Metastatic Uveal Melanoma: Systematic Review
por: Rodriguez-Vidal, Cristina, et al.
Publicado: (2020)

Multiregional genetic evolution of metastatic uveal melanoma
por: Rodriguez, Daniel A., et al.
Publicado: (2021)

Novel treatment paradigms for metastatic uveal melanoma
por: Patel, Sapna P., et al.
Publicado: (2022)

Molecular profiling of driver events in metastatic uveal melanoma
por: Karlsson, Joakim, et al.
Publicado: (2020)

Uveal Melanoma
por: Papastefanou, Vasilios P., et al.
Publicado: (2011)

Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience
por: Karivedu, Vidhya, et al.
Publicado: (2019)

Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma
por: Mignard, Claire, et al.
Publicado: (2018)

Pembrolizumab as first-line treatment for metastatic uveal melanoma
por: Rossi, Ernesto, et al.
Publicado: (2019)

Tebentafusp: T Cell Redirection for the Treatment of Metastatic Uveal Melanoma
por: Damato, Bertil E., et al.
Publicado: (2019)

Identification of novel chemotherapeutic strategies for metastatic uveal melanoma
por: Fagone, Paolo, et al.
Publicado: (2017)

The Role of HGF/MET Signaling in Metastatic Uveal Melanoma
por: Tanaka, Ryota, et al.
Publicado: (2021)

TCR-Directed Therapy in the Treatment of Metastatic Uveal Melanoma
por: Strobel, Sophia B., et al.
Publicado: (2022)

Intermittent MEK inhibition for the treatment of metastatic uveal melanoma
por: Khan, Shaheer, et al.
Publicado: (2022)

Darovasertib, a novel treatment for metastatic uveal melanoma
por: Cao, Lei, et al.
Publicado: (2023)

Long-Term Outcomes in Uveal Melanoma After Ruthenium-106 Brachytherapy
por: Cennamo, Gilda, et al.
Publicado: (2022)

Fractionated stereotactic radiotherapy for uveal melanoma: Long‐term outcome and control rates
por: van Beek, Jackelien G. M., et al.
Publicado: (2021)

Tebentafusp: a first-in-class treatment for metastatic uveal melanoma
por: Howlett, Sarah, et al.
Publicado: (2023)

Predictors of emotional distress in uveal melanoma survivors: a systematic review
por: Davies, Cari, et al.
Publicado: (2022)

The Effect of Intraocular Pressure-Lowering Medication on Metastatic Uveal Melanomas
por: Pals, Jan, et al.
Publicado: (2021)

Presumed Melanoma of Unknown Primary Origin Metastatic to the Choroid Mimics Primary Uveal Melanoma
por: Rieth, John M., et al.
Publicado: (2021)

Uveal Melanoma
por: Pfeffer, Ulrich
Publicado: (2019)

Corrigendum to “Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience”
por: Karivedu, Vidhya, et al.
Publicado: (2019)

Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
por: Schilling, Bastian, et al.
Publicado: (2015)

A novel combinatorial treatment option for metastatic uveal melanoma
por: Shneor, Dudi, et al.
Publicado: (2018)

Improving therapy in metastatic uveal melanoma by understanding prior failures
por: Olson, Daniel J., et al.
Publicado: (2020)

Molecular Insights and Emerging Strategies for Treatment of Metastatic Uveal Melanoma
por: Mallone, Fabiana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nor14o2j3um7vftkr0gvarsb1k